
CPHI Milan 2026
10/2026 – 10/2026
Gentec Pharmaceutical Group's main business is manufacturing and commercializing high-potency active pharmaceutical ingredients and standard APIs. Its Pharmanoid division develops and manufactures prostaglandins and similar compounds, with facilities and quality systems following cGMP and recommended practices for handling high-containment compounds, covering all activities from R&D and analysis to production, including chemical synthesis, purification and large-scale chromatography.

Chưa có bình luận nào.
Để lại đánh giá & nhận xét